Lübbe A S
Freie Universität Berlin, Universitätsklinikum Rudolf Virchow, Medizinische Klinik und Poliklinik (Hämatologie, Onkologie, Poliklinik, Federal Republic of Germany.
Cancer Chemother Pharmacol. 1993;31(4):295-300. doi: 10.1007/BF00685674.
Doxorubicin HCl (Doxo) is an established intercalating antitumor drug. Specific side effects of Doxo primarily affect the cardiac muscle tissue to cause cardiac arrhythmias and chronic cardiomyopathies. The mechanism of action of these side effects is incompletely understood. Thus, the first objective of the present study was to test whether Doxo might have a direct effect on the microcirculation of muscular tissue. We studied large and small arterioles and large venules in the cremaster muscle of rats before and after sequential infusion of 1 (low-dose) and 10 mg/kg (high-dose) Doxo. Large arterioles showed some constriction after low Doxo doses and pronounced constriction after high Doxo doses, whereas small arterioles showed a variable response to low Doxo doses. At high Doxo doses, small arterioles dilated almost maximally (80% of the maximal response to nitroprusside). The heart rate and the diameter of large venules did not change at high Doxo doses, although the blood pressure decreased. This indicates that Doxo directly affects skeletal muscle arterioles. The second purpose of this study was to determine whether local hyperthermia would influence the microcirculation of muscular tissue such that the systemic concentration of Doxo could be reduced. In this second series of experiments, we tested whether local hyperthermia would have an effect on the skeletal muscle microvasculature and whether Doxo would change that response. Local hyperthermia alone did not alter the diameter of small arterioles or large venules, but we observed constriction of large arterioles at temperatures above 37 degrees C and during continued (60-min) hyperthermia at 40 degrees C. The low dose of Doxo did not alter these microvascular diameters at 40 degrees C. However, local hyperthermia at 40 degrees C changed the response of small arterioles to low doxo doses (no vasodilation was observed). Large arterioles continued to constrict in response to Doxo during hyperthermia. These data suggest that large arteriolar responses could be partly responsible for the toxic effect of Doxo on cardiac muscle and that local hyperthermia potentiates that response.
盐酸多柔比星(Doxo)是一种公认的嵌入型抗肿瘤药物。Doxo的特定副作用主要影响心肌组织,导致心律失常和慢性心肌病。这些副作用的作用机制尚不完全清楚。因此,本研究的首要目标是测试Doxo是否可能对肌肉组织的微循环有直接影响。我们在大鼠提睾肌中先后输注1mg/kg(低剂量)和10mg/kg(高剂量)Doxo之前和之后,研究了大、小动脉和大静脉。低剂量Doxo后大静脉出现一些收缩,高剂量Doxo后出现明显收缩,而小动脉对低剂量Doxo表现出可变反应。在高剂量Doxo时,小动脉几乎最大程度扩张(达到对硝普钠最大反应的80%)。高剂量Doxo时,尽管血压下降,但心率和大静脉直径未改变。这表明Doxo直接影响骨骼肌小动脉。本研究的第二个目的是确定局部热疗是否会影响肌肉组织的微循环,从而降低Doxo的全身浓度。在这一系列的第二个实验中,我们测试了局部热疗是否会对骨骼肌微血管产生影响,以及Doxo是否会改变这种反应。单独的局部热疗并没有改变小动脉或大静脉的直径,但我们观察到在温度高于37摄氏度时以及在40摄氏度持续(60分钟)热疗期间大静脉出现收缩。低剂量的Doxo在40摄氏度时并没有改变这些微血管直径。然而,40摄氏度的局部热疗改变了小动脉对低剂量Doxo的反应(未观察到血管舒张)。热疗期间,大静脉继续对Doxo产生收缩反应。这些数据表明大静脉反应可能部分导致Doxo对心肌的毒性作用,并且局部热疗会增强这种反应。